Investors might want to bet on Corcept Therapeutics (CORT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

NEW YORK--(BUSINESS WIRE)--Blueground, the largest global operator of furnished, flexible rentals for 30+ day stays, announces its partnership with CORT Furniture Rental - the nation’s leading ...

Corcept Therapeutics Incorporated (CORT) stock saw a modest uptick, ending the day at $42.25 which represents a slight increase of $1.33 or 3.25% from the prior close of $40.92. The stock opened at ...

Inflation trends have been affecting the prices of all kinds of home items, from groceries to furniture. So, what if you need to stock up on furniture with a smaller budget? This might seem ...

Corcept Therapeutics (CORT) shares soared 6.5% in the last trading session to close at $42.27. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

Corcept (CORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Corcept, Amneal, Bioventus, Foghorn and Akebia have ...

In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Corcept Therapeutics (CORT – Research Report). The ...

Corcept Shares Rise More Than 45% in Six Months: Here's Why Shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) have gained 46.2% in the past six months against the industry's decline of 2%.

Investors might want to bet on Corcept Therapeutics (CORT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...